Zhijun Su

1.2k total citations
47 papers, 822 citations indexed

About

Zhijun Su is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Zhijun Su has authored 47 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Epidemiology, 17 papers in Hepatology and 10 papers in Infectious Diseases. Recurrent topics in Zhijun Su's work include Hepatitis B Virus Studies (19 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis C virus research (13 papers). Zhijun Su is often cited by papers focused on Hepatitis B Virus Studies (19 papers), Liver Disease Diagnosis and Treatment (13 papers) and Hepatitis C virus research (13 papers). Zhijun Su collaborates with scholars based in China, United States and Canada. Zhijun Su's co-authors include Xueping Yu, Ruyi Guo, Yingzhong Li, Darrell J. Irvine, Ron Weiss, Yong Deng, Desong Ming, K. Dane Wittrup, Weiyu Zhao and Noor Momin and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Virology and Scientific Reports.

In The Last Decade

Zhijun Su

42 papers receiving 814 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhijun Su China 17 310 280 267 194 125 47 822
Dianxing Sun China 17 399 1.3× 233 0.8× 448 1.7× 337 1.7× 187 1.5× 45 1.1k
Xiaojun Hu China 18 264 0.9× 127 0.5× 166 0.6× 170 0.9× 75 0.6× 65 1.2k
Ian Gaël Rodrigue‐Gervais Canada 11 571 1.8× 356 1.3× 199 0.7× 137 0.7× 104 0.8× 13 880
Fanyun Kong China 18 372 1.2× 163 0.6× 274 1.0× 145 0.7× 84 0.7× 49 791
António P. Baptista Portugal 16 303 1.0× 690 2.5× 169 0.6× 63 0.3× 153 1.2× 24 1.1k
Hongjuan You China 19 411 1.3× 399 1.4× 406 1.5× 110 0.6× 98 0.8× 36 965
Michael D. Stutz Australia 12 576 1.9× 132 0.5× 198 0.7× 94 0.5× 41 0.3× 15 850
Xavier Legras United States 11 404 1.3× 317 1.1× 129 0.5× 54 0.3× 103 0.8× 14 726
Yanlin Zhao China 16 419 1.4× 189 0.7× 306 1.1× 43 0.2× 178 1.4× 45 986
Guangyun Tan China 17 331 1.1× 385 1.4× 356 1.3× 272 1.4× 66 0.5× 30 962

Countries citing papers authored by Zhijun Su

Since Specialization
Citations

This map shows the geographic impact of Zhijun Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhijun Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhijun Su more than expected).

Fields of papers citing papers by Zhijun Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhijun Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhijun Su. The network helps show where Zhijun Su may publish in the future.

Co-authorship network of co-authors of Zhijun Su

This figure shows the co-authorship network connecting the top 25 collaborators of Zhijun Su. A scholar is included among the top collaborators of Zhijun Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhijun Su. Zhijun Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Guo, Zhixiang, et al.. (2025). Effect of HBeAg/anti-HBe coexistence on HBeAg seroconversion in treatment-naïve chronic hepatitis B patients with peginterferon-α. Therapeutic Advances in Gastroenterology. 18. 1128501013–1128501013. 1 indexed citations
3.
4.
5.
Liu, Cen, et al.. (2023). RAS‐targeted cancer therapy: Advances in drugging specific mutations. SHILAP Revista de lepidopterología. 4(3). e285–e285. 13 indexed citations
6.
Yang, Yuping, Xiaoxiao Fan, Yongjian Liu, et al.. (2023). Function and inhibition of DYRK1A: Emerging roles of treating multiple human diseases. Biochemical Pharmacology. 212. 115521–115521. 19 indexed citations
7.
8.
Ke, Qiao, Xueping Yu, Xuan Wang, et al.. (2023). Prevalence, clinical characteristics, and outcomes of spontaneous portosystemic shunt in patients with hepatitis B-related cirrhosis: A multicenter study from China. Digestive and Liver Disease. 55(10). 1382–1390. 1 indexed citations
9.
10.
Yu, Xueping, Yongjun Zhou, Jian Sun, et al.. (2022). Decreased frequency of a novel T‐lymphocyte subset, CD3 + CD4 − CD7 + CD57 − T cells, in hepatitis B virus‐related end‐stage liver disease might contribute to disease progression. Journal of Medical Virology. 95(1). e28129–e28129. 4 indexed citations
11.
Pang, Xinxin, et al.. (2022). Botany, ethnopharmacology, phytochemistry and pharmacology of Erodii Herba Geranii Herba-An review. Journal of Ethnopharmacology. 302(Pt A). 115858–115858. 8 indexed citations
12.
Su, Zhijun, et al.. (2019). Management practice and thinking of different DRGs grouped patients in clinical pathway. Zhonghua yiyuan guanli zazhi. 35(7). 548–553. 1 indexed citations
13.
Guo, Hongying, Shu Li, Jing Li, et al.. (2019). Development and Validation of a Novel Model to Predict Liver Histopathology in Patients with Chronic Hepatitis B. BioMed Research International. 2019. 1–8. 3 indexed citations
14.
Yu, Xueping, et al.. (2019). BTLA/HVEM Signaling: Milestones in Research and Role in Chronic Hepatitis B Virus Infection. Frontiers in Immunology. 10. 617–617. 66 indexed citations
15.
Li, Yingzhong, Brian Teague, Yuan Zhang, et al.. (2019). In vitro evolution of enhanced RNA replicons for immunotherapy. Scientific Reports. 9(1). 6932–6932. 55 indexed citations
16.
Ming, Desong, et al.. (2015). Elevated TGF-β1/IL-31 Pathway Is Associated with the Disease Severity of Hepatitis B Virus–Related Liver Cirrhosis. Viral Immunology. 28(4). 209–216. 30 indexed citations
17.
Su, Zhijun, et al.. (2013). Changes in the balance between Treg and Th17 cells in patients with chronic hepatitis B. Diagnostic Microbiology and Infectious Disease. 76(4). 437–444. 32 indexed citations
18.
Su, Zhijun & Desong Ming. (2010). Detection of blaTEM-116, ant (3″)-I of resistant-related genes in a Chryseobacterium meningosepticum strain in sputa from a severe chronic hepatitis patient.. Zhongguo yiyuan ganranxue zazhi. 20(6). 767–769. 1 indexed citations
19.
Wu, Ting, Jun Zhang, Zhijun Su, et al.. (2008). Specific Cellular Immune Response in Hepatitis E Patients. Intervirology. 51(5). 322–327. 16 indexed citations
20.
Su, Zhijun, et al.. (2000). Prospective study of nosocomial infection in 848 cases of liver diseases. World Journal of Gastroenterology. 6. 63–63. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Dianxing Sun Breakdown of academic impact, for papers by Xiaojun Hu Breakdown of academic impact, for papers by Ian Gaël Rodrigue‐Gervais Breakdown of academic impact, for papers by Fanyun Kong Breakdown of academic impact, for papers by António P. Baptista Breakdown of academic impact, for papers by Hongjuan You Breakdown of academic impact, for papers by Michael D. Stutz Breakdown of academic impact, for papers by Xavier Legras Breakdown of academic impact, for papers by Yanlin Zhao Breakdown of academic impact, for papers by Guangyun Tan
Rankless by CCL
2026